Cancer · 1953 · 79 citations · 19 references
MedicineOncologyPathologyBone MetabolismMetabolismMetastasisBone Metabolism DisordersBone PathologyBone TissueBone TumorsMetabolic Bone DiseaseMetastatic Bone DiseaseBone Enzyme MarkersBone Tumor MetastasisOsteolytic Bone MetastasisPhosphatase Enzyme ActivitySerum Calcium Measurement
NTEREST IN metabolic changes in bones that I are the site of metastatic cancer dates from early studies on the metabolism of normal bone, but it was not until convenient and reliable methods for the determination of phosphatase in serum and tissue were developed by Bodansky, by King and Armstrong, and by Franseen and hlcLean that satisfactory observations could be made. It was early observed that the alkaline-phosphatase activity of the serum or plasma of some patients with carcinoma metastatic to bone was greater than n o r ~n a l , ~~ 7 and that such elevations were more frequent when the metastases were osteoplastic than when they were osteolytic. Although it was thus evident that there was a general correspondence between the degree of osteoplasia of metastatic lesions of bone and the magnitude of the elevation in the alkaline phosphatase of the serum, and although it had already been shown8 that there was abundant alkaline phosphatase in the tissue at the site of osteoplastic metastases, yet the studies of Woodard and Higinbotham indicated that there were numerous cases in which the correspondence was poor.
19